Olena Zimba
LightNews LightNews
banner
ozimba.bsky.social
Olena Zimba
@ozimba.bsky.social
140 followers 380 following 4 posts
I’m a rheumatologist from Ukraine continuing my professional journey in Poland @rheumteam.bsky.social. Passionate about patient care & advancing medical science, I also contribute to DOAJ, promoting OA to knowledge for a better future.
Posts Replies Media Videos
Reposted by Olena Zimba
thelancetrheum.bsky.social
Our October issue is live!

Including research on #vaccination in #rheumatoidarthritis and
#hydroxychloroquine during #pregnancy, two Reviews on #VEXAS, plus much more! thelancet.com/journals/lan...
Cover by Sara Gironi Carnevale #Medsky #Rheumsky
September 23, 2025 at 11:20 AM
Reposted by Olena Zimba
reumatologiaj.bsky.social
🆕 The new issue of Reumatologia is out!
reu.termedia.pl
🧬 IL-6 signalling – what rheumatologists should know
💉 Collagen injections for greater trochanter pain
🩻 Expert statement on osteoarthritis diagnosis & treatment
and much more!!
May 12, 2025 at 8:37 AM
Reposted by Olena Zimba
reumatologiaj.bsky.social
📢 New Issue Alert – Reumatologia 3/2025 is now online!
reu.termedia.pl
✅Castleman disease
✅ Role of MRI in AxSpA monitoring
✅ Spinal collagen mesotherapy for thoracic back pain
✅ Radiosynoviorthesis – “joints and needles” in summary
✅Can CPPD mimic polymyalgia rheumatica?
and much more!!
July 27, 2025 at 6:53 PM
Reposted by Olena Zimba
reumatologiaj.bsky.social
Do you know the difference between unicentric and multicentric Castleman disease?
New editorial doi.org/10.5114/reum...
highlights key diagnostic and treatment insights — including the role of IL-6, the TAFRO variant, and promising outcomes with siltuximab in idiopathic MCD.
July 27, 2025 at 6:55 PM
Reposted by Olena Zimba
reumatologiaj.bsky.social
Exciting News!🎉
The journal Reumatologia has achieved a new Impact Factor of 1.7 in the 2024 Journal Citation Reports!
Thank you to our authors, reviewers, and editorial team for your continued trust and support.
Let’s keep growing together! ❤️
June 19, 2025 at 9:33 AM
Reposted by Olena Zimba
mjrjournal.bsky.social
🎉 Big milestone for the Mediterranean Journal of Rheumatology!
We are proud to announce our first-ever Impact Factor: 1.4 (JCR 2024) 📊✨
This achievement reflects the dedication of our authors, reviewers, and editorial team — thank you for being part of this journey!
June 19, 2025 at 9:19 AM
ozimba.bsky.social
Grateful to receive Springer Nature Editorial Contribution Award 2025 for Clinical Rheumatology and Rheumatology International.
Deeply appreciate the support of all colleagues – authors, reviewers, editors – for the inspiring teamwork & shared commitment to science.
June 4, 2025 at 8:26 PM
Reposted by Olena Zimba
uksg.bsky.social
The latest from #UKSGInsights - "Open infrastructures in conflict zones: a case study of @doaj.bsky.social and Ukrainian journals" (Authors: @ozimba.bsky.social, @katrinesundsbo.bsky.social, Natalia Laiuzhna and Iemima Ploscaru) dub.sh/rVBTHTI
This case study explores the role of the Directory of Open Access Journals (DOAJ) in increasing the visibility and accessibility of Ukrainian academic journals. Ukrainian journals face numerous challenges due to economic constraints and the ongoing war. The article presents how open infrastructures play an important role in supporting journals during conflict, invasion or major disruption, using DOAJ as a case study. It analyzes what has worked and what could have been improved in DOAJ’s approach, including its collaborative efforts with the Supporting Ukrainian Editorial Staff (SUES) project, the Open Ukrainian Citation Index (OUCI) and Research4Life as initiatives to increase the visibility, transparency and impact of all digitized Ukrainian academic journals, despite the ongoing war with Russia. Recommendations are presented to increase the quality and visibility of Ukrainian journals and to guide open infrastructures in supporting journals from conflict areas.
June 3, 2025 at 12:05 PM
ozimba.bsky.social
I am honored to be recognized as an Honorary Member of the Croatian Society for Rheumatology!
Grateful to all Croatian rheumatologists for this award.
February 18, 2025 at 6:42 PM
Reposted by Olena Zimba
acr-journals.bsky.social
This week in AC&R #Medsky

Interventions for fibromyalgia-related sleep problems
doi.org/10.1002/acr....

SLE mortality trends in the US 1999-2020
doi.org/10.1002/acr....

Frequency of SLE flares in patients with end-stage renal disease on renal replacement therapy
doi.org/10.1002/acr....
ACR journals weekly recap banner - Arthritis Care & Research cover
February 15, 2025 at 1:41 PM
Reposted by Olena Zimba
eloquenti.com
🦋A starter pack of organizations offering research funding🧪 💵 💶 💷

#research #science #innovation #funding #grants #grant #ResearchFunding #ResearchSupport #FundingOpportunities #funding #NIH #ERC #HorizonEurope #DFG #ANR #AcademicSky #AcademicChatter #PhD #PhDChat #PostDoc #ECR #ECRChat #NewPI
February 13, 2025 at 11:39 AM
Reposted by Olena Zimba
rheumteam.bsky.social
🔥A must-read for #rheumatology specialists!
A NEW review by our colleague
@joannawegiel.bsky.social
explores the diverse clinical presentations of #EGPA, its diagnostic complexities, and the role of #ANCA status in guiding prognosis.
👉 doi.org/10.5114/reum...
#vasculitis
February 6, 2025 at 6:07 PM
Reposted by Olena Zimba
acr-journals.bsky.social
New special collection of articles in ACR Open Rheumatology on diet and rheumatic disease. All articles in ACROR are open access

Read the collection: acr.tw/4hNFDBk
ACR Open Rheumatology special collection on diet and rheumatic disease banner
February 9, 2025 at 5:02 PM
Reposted by Olena Zimba
rheumteam.bsky.social
🦋New Study on #lupusNephritis by @joannawegiel.bsky.social et al. @rheumteam.bsky.social
reveals key differences in LN vs. non-LN cases
Read more👉https://doi.org/10.3390/jcm13154486
February 13, 2025 at 9:51 AM
Reposted by Olena Zimba
rheumteam.bsky.social
🧐Could #SLE ⬆️ #cancer risk?
👉https://doi.org/10.1007/s00296-024-05623-3
by @joannawegiel.bsky.social @rheumteam.bsky.social
✅1 in 10 SLE patients develop malignancy
✅Linked to older age at SLE onset&longer disease duration
✅Aggressive immunosuppression with CYC more common
Regular screening is key!
February 13, 2025 at 9:59 AM
Reposted by Olena Zimba
rheumteam.bsky.social
📢 #Norwegian Amb.Øystein Bø meets @rheumteam.bsky.social to discuss collaboration:
🔹 #POLNORRheuma project
🔹 #GoTreatIT system in PL rheumatology centers
🔹 1,200+ patients & 10,000+ serum samples
🔹 Stronger European rheumatology registry ties
Global partnerships drive innovation in #rheumatology!
February 13, 2025 at 10:14 AM
Reposted by Olena Zimba
rheumteam.bsky.social
Did you know that #SleepDisorders affect up to 92% of people with #InflammatoryArthritis ?
🔥A new review by @dagnapolak.bsky.social @zofiagula.bsky.social
👉https://doi.org/10.1007/s00296-024-05780-5
highlights the complex links between chronic inflammation, pain and poor sleep in #RA #axSpA #PsA
February 13, 2025 at 10:26 AM
Reposted by Olena Zimba
thelancetrheum.bsky.social
NEW REVIEW—The concept of difficult-to-treat disease in #rheumatology: where next?

www.thelancet.com/journals/lan... #Medsky #Rheumsky
The concept of difficult-to-treat disease in rheumatology: where next?
New pathogenesis-based therapeutics and evidence-based consensus treatment recommendations, often with predefined treatment goals, have remarkably improved outcomes across many chronic diseases. Howev...
www.thelancet.com
February 12, 2025 at 2:23 PM
Reposted by Olena Zimba
thelancetrheum.bsky.social
Our Feb issue is live!

Including research on #CAR T cells in #SystemicSclerosis, developing #arthritis educational resources for Aboriginal people, post-COVID sequelae, MRI assessments in #PsoriaticArthritis, plus much more! thelancet.com/journals/lan...
Cover by Sara Gironi Carnevale
February 3, 2025 at 3:44 PM
Reposted by Olena Zimba
proceedingssss.bsky.social
Introducing "The Proceedings of the Shevchenko Scientific Society. Medical Sciences" 📚🔬

We are proud to present a peer-reviewed academic journal dedicated to advancing medical knowledge and fostering scholarly dialogue in Ukraine and Eastern Europe.

📥 mspsss.org.ua/index.php/jo...
February 3, 2025 at 5:41 PM
Reposted by Olena Zimba
proceedingssss.bsky.social
Volume 76 No. 2 (2024) published (mspsss.org.ua/index.php/jo...)

We sincerely thank all the Аuthors for their invaluable contributions to advancing medical science and supporting the growth of Ukrainian research!

#MedicalResearch
#AcademicExcellence
#MedicalSciences
#EasternEuropeMedicine
February 5, 2025 at 7:34 PM
Reposted by Olena Zimba
uoyopenres.bsky.social
We address this briefly as part of our Open Research Skills Framework, but it's an area where we could probably provide further support and raise some awareness 👇
Subject Guides: Open Research Skills Framework: a Practical Guide: Open Research Lifecycle
This Practical Guide provides helpful support and links to recommended external resources for a range of open research practices.
subjectguides.york.ac.uk
January 28, 2025 at 4:57 PM
Reposted by Olena Zimba
rheumteam.bsky.social
🔬 New Study: #Serotonin in #InflammatoryArthritis using advanced LC-MS technology
✅Elevated in #RA #PsA #axSpA vs. controls
✅No link to disease activity scores
✅Tied to worse physical health, not psychological
👉https://rdcu.be/d5124
January 12, 2025 at 5:42 PM
Reposted by Olena Zimba
rheumteam.bsky.social
Congratulations to Dr. Jaroslaw Nowakowski and his mentor, Prof. Mariusz Korkosz on the prestigious doctoral promotion! 🎉
The ceremony at Jagiellonian University was a memorable celebration of academic achievements.
We wish Dr. Nowakowski continued success & new milestones in his scientific career
January 19, 2025 at 4:34 PM
Reposted by Olena Zimba
rheumteam.bsky.social
📢 Just published.
CV Comorbidities in #PsA by Jarosław Nowakowski and colleagues
@rheumteam.bsky.social
👉 dx.doi.org/10.20452/pam...
✅ Oligoarthritis & GCs predict CV comorbidities
✅ GCs/NSAIDs linked to ⬆️ CV risks
✅ Hyperlipidemia underdiagnosed—better screening needed
February 6, 2025 at 6:05 PM